Anupam Rasayan declares interim dividend
Anupam Rasayan India Ltd. (ARIL) on Tuesday, July 15, announced several key decisions following its board meeting. The company declared an interim dividend, approved a preferential allotment of equity shares, and set a record date for the dividend payout.
The board has declared an interim dividend of ₹0.75 per share (7.5% of the face value of ₹10 each) for the financial year 2024-25. The record date for determining the eligibility of shareholders is July 21, 2025, and the dividend will be paid on or before August 13, 2025.
Additionally, the board approved the allotment of 39,14,886 fully paid-up equity shares on a preferential basis at an issue price of ₹945.11 per share (including a premium of ₹935.11 per share), amounting to approximately ₹277.5 crore, after receiving the remaining 75% of the issue price. These shares were allotted under the non-promoter category to the following investors: Lata Manek Bhanshali : 5,29,038 shares
Zeal Global Opportunities Fund (FPI) : 16,92,924 shares
Zinnia Global Fund PCC – Cell Dewcap (FPI): 16,92,924 shares
The board meeting commenced at 5:32 PM IST and concluded at 6:13 PM IST.
These developments reflect the company's continued efforts to reward shareholders and raise funds through strategic investments.
Disclaimer: The above information is based on the company's regulatory filing and is for informational purposes only. Investors are advised to exercise their own judgment and consult their financial advisors before making investment decisions.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
29 minutes ago
- Business Upturn
Smartworks Coworking Spaces shares list at 7% premium at Rs 435 per share on NSE
By Aditya Bhagchandani Published on July 17, 2025, 10:01 IST Shares of Smartworks Coworking Spaces made their stock market debut on Thursday, July 17, listing at a 7% premium over the IPO price. The stock opened at ₹436.10 on the BSE and ₹435 on the NSE, compared to its issue price of ₹407. This performance was in line with grey market expectations, where the shares were commanding a ₹25 premium, indicating around a 6% listing gain. The ₹582.56-crore book-built IPO saw strong demand, being subscribed 13.92 times by investors. Ahead of the IPO, Smartworks raised ₹173.6 crore from institutional investors such as Tata Mutual Fund, Axis New Opportunities AIF, SBI General Insurance, BNP Paribas, and others. Smartworks revised its IPO size down from an earlier planned ₹550 crore fresh issue to ₹445 crore, and reduced the offer for sale by promoters to 33.79 lakh shares from 67.59 lakh. Post IPO, the promoter holding declined from 65% to 59%. Neetish Sarda, Harsh Binani, Saumya Binani, NS Niketan LLP, SNS Infrareality LLP, and Aryadeep Realstates Private Limited are the promoters. The IPO proceeds will primarily be used for capex towards fit-outs in new centres, security deposits, loan repayments, and general corporate purposes. The company offers customised, tech-enabled workspace solutions, leasing large bare-shell properties in prime locations and converting them into fully-serviced campuses with cafeterias, sports zones, gyms, and medical centres. Its operations are spread across Bengaluru, Mumbai, Hyderabad, Gurugram, and Chennai. Between FY23 and FY25, Smartworks grew its managed space by 2.83 million sq. ft., at a CAGR of 20.8%, while adjusted EBITDA grew more than 3.5x to ₹172 crore in FY25. The company's net debt currently stands at about ₹300 crore. JM Financial acted as the book-running lead manager and Link Intime was the registrar for the IPO. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
16 hours ago
- Business Upturn
Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India
By Aditya Bhagchandani Published on July 16, 2025, 17:23 IST Emcure Pharmaceuticals Ltd. and Sanofi India Ltd. (SIL) have announced an exclusive distribution and promotion agreement for Sanofi's oral anti-diabetic (OAD) products in India, effective immediately. Under this partnership, Emcure will distribute and promote SIL's widely prescribed OAD brands, including Amaryl® and Cetapin®, leveraging its deep reach and network across India. Sanofi will continue to own and manufacture these products at its plants in India and globally. The collaboration aims to expand access to trusted oral diabetes medicines to millions of patients across the country. Notably, there will be no employee transfers from Sanofi to Emcure as part of this deal. Eric Mansion, GM Pharma Southeast Asia and India at Sanofi, said: 'Over 100 million Indians live with type 2 diabetes, and more than 60% have uncontrolled blood sugar levels. With Emcure's reach, we aim to unlock the full potential of our industry-leading OADs for patients and healthcare professionals.' Satish Mehta, CEO & MD of Emcure, added: 'This partnership aligns with our mission to improve patient access to high-quality therapies and complements our existing diabetes portfolio, supporting better diabetes care nationwide.' This alliance brings together Sanofi's strong brand portfolio and Emcure's extensive distribution network, strengthening both companies' presence in the critical diabetes care segment. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
16 hours ago
- Business Upturn
Hindustan Zinc secures LoI for Rajasthan potash and halite block
Hindustan Zinc Limited (HZL) announced on July 16, 2025, that it has received a Letter of Intent (LoI) from the Ministry of Mines, Government of India, confirming it as the preferred bidder for the Jhandawali–Satipura Amalgamated Potash and Halite Block in Rajasthan. The LoI was issued under Rule 18(1) of the Mineral Auction Rules, 2015, following an e-auction conducted by the ministry. The block, located in Hanumangarh district, Rajasthan, spans an area of approximately 1,841.25 hectares and will be granted to HZL as a composite license (covering both prospecting and mining). This acquisition is aligned with HZL's strategy to diversify into other minerals and expand its resource base beyond zinc and lead. The company had earlier intimated about its bid through a letter dated May 28, 2025, and the receipt of the LoI marks the next step toward operationalizing this resource. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
